ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
AI Entrar Premium IconPremium Help Menu
Índice Bovespa
127.492,49
1,22%
S&P 500
5.459,10
1,11%
US Dollar vs BRL
5,6561
0,00%
Bitcoin
67.875,90
-0,06%
Brent Oil
79,745
0,00%
Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NYSE
  6. AbbVie Inc (ABBV)

  7. AbbVie Inc (ABBV) Notícias

ABBV AbbVie Inc

185,00
2,83 (1,55%)
26 Jul 2024 - Fechado
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
AbbVie Inc ABBV NYSE Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
Upgrade Icon
2,83 1,55% 185,00 21:00:00
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
183,85 182,11 186,85 185,16 182,17
mais cotações »

Notícias Recentes

Data Hora Fonte Título
26/07/202403:00PRNUSAbbVie Announces European Commission Approval of SKYRIZI®..
25/07/202408:36PRNUSAbbVie Reports Second-Quarter 2024 Financial Results
25/07/202407:21IHMARKETNEWSU.S. Index Futures Mixed After Tech Sell-Off, Oil Prices..
23/07/202408:02PRNCAL'Agence des médicaments du Canada octroie à AbbVie sa toute..
12/07/202409:30PRNUSAbbVie Submits Regulatory Applications to FDA and EMA for..
10/07/202409:00PRNUSAbbVie Announces Appointment of Roopal Thakkar, M.D. as..
05/07/202409:13IHMARKETNEWSTesla Listed for China’s Government Vehicles; Macy’s..
02/07/202409:00PRNUSAbbVie to Host Second-Quarter 2024 Earnings Conference Call
01/07/202409:00PRNUSRobert A. Michael Assumes Role as AbbVie Chief Executive..
28/06/202403:00PRNUSAbbVie Receives Positive CHMP Opinion for Epcoritamab..
27/06/202410:26PRNUSAbbVie Acquires Celsius Therapeutics
27/06/202409:30PRNUSIntroducing Allē Payment Plans, Powered by Cherry
26/06/202420:03PRNUSU.S. Food and Drug Administration Grants Second Approval for..
25/06/202409:15PRNUSAbbVie Provides U.S. Regulatory Update on ABBV-951..
21/06/202409:00PRNUSAbbVie Declares Quarterly Dividend
20/06/202409:00PRNUSAbbVie Appoints Roxanne S. Austin as Lead Independent..
18/06/202419:18PRNUSU.S. FDA Approves SKYRIZI® (risankizumab-rzaa) for..
14/06/202417:08PRNUSAbbVie Recommends Shareholders Reject Tutanota's..
13/06/202408:59PRNUSAbbVie and FutureGen Announce License Agreement to Develop..
11/06/202409:00PRNUSBOTOX® Cosmetic (onabotulinumtoxinA) Reveals 2024 Women..
06/06/202409:45PRNUSAbbVie Announces Positive Topline Results from Phase 2..
06/06/202409:30PRNUSSkinMedica® Celebrates 25 Years of Empowering Radiant Skin
06/06/202409:00PRNUSAbbVie Launches First-of-its-Kind Contest to Empower People..
05/06/202410:00PRNUSAbbVie Advances Oncology Pipeline With Start of Multiple..
04/06/202409:30PRNUSRINVOQ® (upadacitinib) Now Available for Pediatric Patients..
04/06/202409:05PRNUSRefer Your Friends to Allē, the Loyalty Rewards Program by..
03/06/202409:30PRNUSAbbVie to Present at the Goldman Sachs 45th Annual Global..
31/05/202403:00PRNUSAbbVie Receives Positive CHMP Opinion for Risankizumab..
28/05/202409:00PRNUSAbbVie Showcases Robust Solid Tumor Pipeline at ASCO 2024..
23/05/202417:05PRNUSAbbVie Completes Acquisition of Landos Biopharma
17/05/202408:30PRNUSAbbVie Presents New Data Supporting Leading Gastroenterology..
13/05/202409:39PRNUSAbbVie and Gilgamesh Pharmaceuticals Announce Collaboration..
08/05/202409:00PRNCAQULIPTA™ (atogepant) Now Approved by Health Canada for the..
06/05/202409:00PRNUSAbbVie to Present at the Bank of America Securities..
26/04/202408:47IHMARKETNEWSU.S. Futures Climb in Pre-Market Trading Amid Tech Gains and..
26/04/202408:35PRNUSAbbVie Reports First-Quarter 2024 Financial Results
25/04/202409:00PRNUSNew Data Show RINVOQ® (upadacitinib) Demonstrated..
23/04/202409:00PRNUSAllergan Aesthetics Invites Consumers to Be the Face of..
18/04/202409:31PRNUSPhase 3 SELECT-GCA Study of Upadacitinib (RINVOQ®) Showed..
12/04/202408:30PRNUSAbbVie Announces Late-Breaking Data at AAN Supporting..
09/04/202409:00PRNUSSkinMedica® Empowers Clear Skin Confidence with a New,..
04/04/202409:00PRNUSAbbVie to Host First-Quarter 2024 Earnings Conference Call
03/04/202409:30PRNUSAllergan Aesthetics Announces the Return of CoolMonth with..
01/04/202408:50GLOBENEXGEL Reports Full Year 2023 Revenue of $4.1 Million, an..
26/03/202408:20IHMARKETNEWSSuper Micro Computer and Seagate Shares Surge on Analyst..
25/03/202412:00PRNUSAllergan Aesthetics Launches "Moving the Needle on Ethics"..
25/03/202409:31PRNUSAbbVie to Acquire Landos Biopharma, Further Strengthening..
25/03/202409:30GLOBEAbbVie to Acquire Landos Biopharma, Further Strengthening..
22/03/202416:02PRNUSU.S. Food and Drug Administration (FDA) Grants Full Approval..
21/03/202409:00PRNUSALLERGAN AESTHETICS CONTINUES TO CHAMPION INDIVIDUALITY,..

Seu Histórico Recente

NYSE
ABBV
AbbVie
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados